Literature DB >> 2476566

Murine cell-mediated immune response recognizes an enterovirus group-specific antigen(s).

M A Beck1, S M Tracy.   

Abstract

Splenocytes taken from mice inoculated with coxsackievirus B3 (CVB3) (Nancy) developed an in vitro proliferative response against CVB3 antigen. This response could not be detected earlier than 8 days postinoculation but could be detected up to 28 days after exposure to CB3. CVB3-sensitized splenocytes responded not only to the CVB3 antigen but to other enteroviruses as well. This response was found to be enterovirus specific in that no response was detected to a non-enteroviral picornavirus, encephalomyocarditis virus, or to an unrelated influenza virus. The generation of a splenocyte population capable of responding to an enterovirus group antigen(s) was not limited to inoculation of mice with CVB3, as similar responses were generated when mice were inoculated with CVB2. Cell subset depletions revealed that the major cell type responding to the enterovirus group antigen(s) was the CD4+ T cell. Current evidence suggests that the group antigen(s) resides in the structural proteins of the virus, since spleen cells from mice inoculated with a UV-inactivated, highly purified preparation of CVB3 virions also responded in vitro against enteroviral antigens.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476566      PMCID: PMC251028     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Isolation of Coxsackievirus B3 temperture-sensitive mutants and their assignment to complementation groups.

Authors:  M D Trousdale; R E Paque; C J Gauntt
Journal:  Biochem Biophys Res Commun       Date:  1976-05-23       Impact factor: 3.575

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Structure of a human common cold virus and functional relationship to other picornaviruses.

Authors:  M G Rossmann; E Arnold; J W Erickson; E A Frankenberger; J P Griffith; H J Hecht; J E Johnson; G Kamer; M Luo; A G Mosser
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

4.  Immunologic recognition of influenza virus-infected cells. I. Generation of a virus-strain specific and a cross-reactive subpopulation of cytotoxic T cells in the response to type A influenza viruses of different subtypes.

Authors:  T J Braciale
Journal:  Cell Immunol       Date:  1977-10       Impact factor: 4.868

5.  Dengue virus-specific murine T-lymphocyte proliferation: serotype specificity and response to recombinant viral proteins.

Authors:  A L Rothman; I Kurane; Y M Zhang; C J Lai; F A Ennis
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

Review 6.  Enteroviruses in human disease.

Authors:  N R Grist; E J Bell; F Assaad
Journal:  Prog Med Virol       Date:  1978

7.  Relationship of congenital anomalies and maternal infection with selected enteroviruses.

Authors:  G C Brown; R S Karunas
Journal:  Am J Epidemiol       Date:  1972-03       Impact factor: 4.897

8.  Coxsackievirus B4 myocarditis in mice: valvular changes in virus-infected and control animals.

Authors:  M R el-Khatib; J L Chason; K L Ho; B Silberberg; A M Lerner
Journal:  J Infect Dis       Date:  1978-04       Impact factor: 5.226

9.  Myocardial changes after infection with Coxsackie virus B3 in nude mice.

Authors:  I Hashimoto; T Komatsu
Journal:  Br J Exp Pathol       Date:  1978-02

10.  Differentiation of T-cell precursors in nude mice demonstrated by immunofluorescence of T-cell membrane markers.

Authors:  F Loor; B Kindred
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  14 in total

1.  Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice.

Authors:  N M Chapman; K S Kim; S Tracy; J Jackson; K Höfling; J S Leser; J Malone; P Kolbeck
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes.

Authors:  Amir-Babak Sioofy-Khojine; Jussi Lehtonen; Noora Nurminen; Olli H Laitinen; Sami Oikarinen; Heini Huhtala; Outi Pakkanen; Tanja Ruokoranta; Minna M Hankaniemi; Jorma Toppari; Mari Vähä-Mäkilä; Jorma Ilonen; Riitta Veijola; Mikael Knip; Heikki Hyöty
Journal:  Diabetologia       Date:  2018-02-05       Impact factor: 10.122

3.  Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridization.

Authors:  N M Chapman; S Tracy; C J Gauntt; U Fortmueller
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

4.  Expression of an antigenic adenovirus epitope in a group B coxsackievirus.

Authors:  K Höfling; S Tracy; N Chapman; K S Kim; J Smith Leser
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  Echovirus 22 is an atypical enterovirus.

Authors:  B A Coller; N M Chapman; M A Beck; M A Pallansch; C J Gauntt; S M Tracy
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.

Authors:  K-S Kim; S Tracy; W Tapprich; J Bailey; C-K Lee; K Kim; W H Barry; N M Chapman
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses.

Authors:  N M Chapman; Z Tu; S Tracy; C J Gauntt
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region.

Authors:  Z Tu; N M Chapman; G Hufnagel; S Tracy; J R Romero; W H Barry; L Zhao; K Currey; B Shapiro
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Picornavirus-specific CD4+ T lymphocytes possessing cytolytic activity confer protection in the absence of prophylactic antibodies.

Authors:  Z C Neal; G A Splitter
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus.

Authors:  S Graham; E C Wang; O Jenkins; L K Borysiewicz
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.